WO2009138408A3 - Methods and kits for the diagnosis of rheumatoid arthritis - Google Patents
Methods and kits for the diagnosis of rheumatoid arthritis Download PDFInfo
- Publication number
- WO2009138408A3 WO2009138408A3 PCT/EP2009/055731 EP2009055731W WO2009138408A3 WO 2009138408 A3 WO2009138408 A3 WO 2009138408A3 EP 2009055731 W EP2009055731 W EP 2009055731W WO 2009138408 A3 WO2009138408 A3 WO 2009138408A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- kits
- diagnosis
- methods
- rheumatoid arthritis
- proteins
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/989,806 US8338188B2 (en) | 2008-05-14 | 2009-05-12 | Methods and kits for the diagnosis of rheumatoid arthritis |
JP2011508900A JP5663723B2 (en) | 2008-05-14 | 2009-05-12 | Methods and kits for the diagnosis of rheumatoid arthritis |
EP09745740A EP2286233A2 (en) | 2008-05-14 | 2009-05-12 | Methods and kits for the diagnosis of rheumatoid arthritis |
US13/724,595 US20130178388A1 (en) | 2008-05-14 | 2012-12-21 | Methods and Kits for the Diagnosis of Rheumatoid Arthritis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08305167 | 2008-05-14 | ||
EP08305167.2 | 2008-05-14 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/724,595 Division US20130178388A1 (en) | 2008-05-14 | 2012-12-21 | Methods and Kits for the Diagnosis of Rheumatoid Arthritis |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009138408A2 WO2009138408A2 (en) | 2009-11-19 |
WO2009138408A3 true WO2009138408A3 (en) | 2010-01-14 |
Family
ID=39643997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2009/055731 WO2009138408A2 (en) | 2008-05-14 | 2009-05-12 | Methods and kits for the diagnosis of rheumatoid arthritis |
Country Status (4)
Country | Link |
---|---|
US (2) | US8338188B2 (en) |
EP (1) | EP2286233A2 (en) |
JP (1) | JP5663723B2 (en) |
WO (1) | WO2009138408A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2336769A1 (en) * | 2009-12-18 | 2011-06-22 | F. Hoffmann-La Roche AG | Trigger assay for differentiating between rheumatic and non-rheumatic disorders |
WO2012154705A1 (en) * | 2011-05-10 | 2012-11-15 | Nestec S.A. | Methods for diagnosing degenerative joint disease |
EP2527841A1 (en) | 2011-05-25 | 2012-11-28 | Toscana Biomarkers S.r.l. | Methods for the diagnosis of rheumatoid arthritis |
US10060911B2 (en) * | 2011-08-19 | 2018-08-28 | Protagen Aktiengesellschaft | Method for diagnosis of high-affinity binders and marker sequences |
EP2644704A1 (en) * | 2012-03-27 | 2013-10-02 | Protagen AG | Marker sequences for rheumatoid arthritis |
US20150293120A1 (en) | 2012-03-27 | 2015-10-15 | Protagen Ag | Marker sequences for rheumatoid arthritis |
US20160169906A1 (en) * | 2013-07-31 | 2016-06-16 | Kyoto University | Methods for identifying autoimmune arthritis and for screening for inhibitor of activation of autoimmune arthritogenic t cells |
CA2964472A1 (en) | 2014-10-29 | 2016-05-06 | 10X Genomics, Inc. | Methods and compositions for targeted nucleic acid sequencing |
AU2016289621A1 (en) | 2015-07-03 | 2018-02-22 | Anca CATRINA | Methods and compounds for the alleviation and/or prevention of bone loss |
WO2017168014A1 (en) | 2016-04-02 | 2017-10-05 | Protagen Ag | Marker sequences for rheumatoid arthritis |
CN106950365B (en) * | 2017-02-15 | 2018-11-27 | 中国医学科学院北京协和医院 | A kind of RA diagnosis marker of ACPA feminine gender and its application |
US10742435B2 (en) | 2017-06-29 | 2020-08-11 | Google Llc | Proactive provision of new content to group chat participants |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4208479A (en) * | 1977-07-14 | 1980-06-17 | Syva Company | Label modified immunoassays |
SI1721162T1 (en) * | 2004-02-27 | 2009-02-28 | Roche Diagnostics Gmbh | Method of assessing rheumatoid arthritis by measuring anti-ccp and serum amyloid a |
JP4411416B2 (en) * | 2004-11-09 | 2010-02-10 | 独立行政法人理化学研究所 | Use of anti-citrullinated collagen type I collagen in the diagnosis of rheumatoid arthritis |
US20080026485A1 (en) * | 2006-04-18 | 2008-01-31 | Wolfgang Hueber | Antibody profiling for determination of patient responsiveness |
-
2009
- 2009-05-12 WO PCT/EP2009/055731 patent/WO2009138408A2/en active Application Filing
- 2009-05-12 EP EP09745740A patent/EP2286233A2/en not_active Withdrawn
- 2009-05-12 JP JP2011508900A patent/JP5663723B2/en not_active Expired - Fee Related
- 2009-05-12 US US12/989,806 patent/US8338188B2/en not_active Expired - Fee Related
-
2012
- 2012-12-21 US US13/724,595 patent/US20130178388A1/en not_active Abandoned
Non-Patent Citations (4)
Title |
---|
DE VRIES-BOUWSTRA J K ET AL: "Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.", ARTHRITIS AND RHEUMATISM MAY 2008, vol. 58, no. 5, May 2008 (2008-05-01), pages 1293 - 1298, XP002498678, ISSN: 0004-3591 * |
FENSTERLE JOACHIM ET AL: "B-Raf specific antibody responses in melanoma patients", BMC CANCER, BIOMED CENTRAL, LONDON, GB, vol. 4, no. 1, 12 September 2004 (2004-09-12), pages 62, XP021004664, ISSN: 1471-2407 * |
KIM TAE YONG ET AL: "The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma.", CLINICAL ENDOCRINOLOGY SEP 2006, vol. 65, no. 3, September 2006 (2006-09-01), pages 364 - 368, XP002498677, ISSN: 0300-0664 * |
SUZUKI A ET AL: "Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis", NATURE GENETICS, NATURE PUBLISHING GROUP, NEW YORK, US, vol. 34, no. 4, 1 August 2003 (2003-08-01), pages 395 - 402, XP002979063, ISSN: 1061-4036 * |
Also Published As
Publication number | Publication date |
---|---|
JP2011521216A (en) | 2011-07-21 |
US20110065609A1 (en) | 2011-03-17 |
EP2286233A2 (en) | 2011-02-23 |
US8338188B2 (en) | 2012-12-25 |
US20130178388A1 (en) | 2013-07-11 |
WO2009138408A2 (en) | 2009-11-19 |
JP5663723B2 (en) | 2015-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009138408A3 (en) | Methods and kits for the diagnosis of rheumatoid arthritis | |
WO2012054639A3 (en) | Nmr systems and methods for the rapid detection of analytes | |
WO2011100708A3 (en) | Assay card for sample acquisition, treatment and reaction | |
BRPI1011760A2 (en) | method for preventing or reducing coagulation in the upper gastrointestinal tract of an individual, and use of anticoagulant protein. | |
WO2016013940A3 (en) | Novel test for microbial blood infections | |
WO2008039769A3 (en) | Methods and devices for analyzing small rna molecules | |
WO2009102421A3 (en) | Targeted therapeutics based on engineered proteins that bind egfr | |
WO2012166742A3 (en) | Systems and methods for genetic and biological analysis | |
WO2006036173A3 (en) | Frizzled proteins and detection and treatment of cancer | |
EP3355057A3 (en) | Means and methods for diagnosing pancreatic cancer in a subject | |
WO2011143624A3 (en) | Humanized and chimeric monoclonal antibodies to cd47 | |
WO2007047408A3 (en) | Promac signature application | |
WO2006034328A3 (en) | Wnt proteins and detection and treatment of cancer | |
HK1172931A1 (en) | Methods, primers, probes and kits useful for the detection of braf mutations braf | |
SG155931A1 (en) | Wnt proteins and detection and treatment of cancer | |
WO2011106541A3 (en) | Diagnostic methods involving loss of heterozygosity | |
WO2011015944A3 (en) | Use of free dna as an early predictor of severity in acute pancreatitis | |
WO2007048067A3 (en) | C-kit oncogene mutations in melanoma | |
WO2007114986A3 (en) | Cooperative probes and methods of using them | |
WO2011087709A3 (en) | Eml4-alk translocations in lung cancer | |
WO2009037473A3 (en) | Nucleobase characterisation | |
WO2012017430A3 (en) | Microrna patterns for the diagnosis, prognosis and treatment of melanoma | |
DK2086576T3 (en) | H5 proteins, nucleic acid molecules and vectors encoding them, as well as their medical use | |
IL223076A0 (en) | Novel as160-like protein, test systems, methods and uses involving it for the identification of diabetes type 2 therapeutics | |
WO2009120712A3 (en) | Compositions and methods for diagnosing and treating melanoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09745740 Country of ref document: EP Kind code of ref document: A2 |
|
REEP | Request for entry into the european phase |
Ref document number: 2009745740 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009745740 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011508900 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12989806 Country of ref document: US |